GlaxoSmithKline Pharmaceuticals nv — Belgium · TED award notices · Supplier record: 1 award notices, all years (January 2024); 1 since January 2024 (1 buyer); 12th rank in the line (of 25 suppliers · 4.8%); 9 buyers never served (16 notices in the line from them).
Assay record ASY-BE-1FJIZSC0YP · Cite as: Assay Systems, “GlaxoSmithKline Pharmaceuticals nv in the TED register for Belgium”, https://assay-systems.com/register/be/glaxosmithkline-pharmaceuticals-nv/
1
award notices, all years
January 2024
1
since January 2024
1 buyer
12th
rank in the line
of 25 suppliers · 4.8%
9
buyers never served
16 notices in the line from them
Own record by year
award notices, 2023 onward
1
2023202420252026
Who buys from GlaxoSmithKline Pharmaceuticals nv
since January 2024
1buyers
1notices
100%top buyer
Hospilim VZW100.0%
1 notice
The line
since January 2024
21award notices
10buyers
25suppliers
67.3%held by top ten
Medicinal products for the nervous system and sensory organs (CPV 33660000)
9
5
7
202420252026Jan–Sep
12thof 25 suppliers
1notices name GlaxoSmithKline Pharmaceuticals nv
4.8%share of the line
20.0%of 5 notices from Hospilim VZW
7new suppliers since 2025
Buyers that buy the line and never named GlaxoSmithKline Pharmaceuticals nv
Source: contract award notices for Belgium in Tenders Electronic Daily (TED), Publications Office of the European Union, ted.europa.eu, reusable for commercial purposes under Commission Decision 2011/833/EU; notices from November 2023, when TED began to publish the winning supplier, to 30 September 2026, accessed 11 October 2026.Assay Systems has changed the data.